Pharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024

Pharmacovigilance and RelatedPharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024 PR Newswire LONDON, April 16, 2014 Post-marketing surveillance for medicines - discover trends, outlooks, and revenues Where are pharmacovigilance and related needs heading? For those pharmaceutical testing studies you get new analysis, also exploring sales predictions. You unlock that medical industry. And you assess its results, trends, technologies, prospects, and opportunities. Visiongain's updated report forecasts those revenues to 2024 at overall world market, regional, and national level. There stay ahead in data, benefiting your influence. And hear about gains for patients, doctors, healthcare providers, and companies. Read on, then, to explore assessments of drugs in use, also finding those services' future commercial value. Analyses exclusive to that study, discussing the most important needs and potentials Demand rises for those testing, data storage, and monitoring operations. There our study benefits your plans, decisions, and authority by interpreting medical needs, regulations, and companies' efforts. Save time and effort. And you see what's happening in surveillance of pharmaceuticals, assessing likely challenges, events, and gains. In particular discover prospects for phase IV clinical trials, contract research organisations (CROs), and pharmaceutical companies. And in those analyses you get data found nowhere else.